Expand LRMR Menu
LRMR MENU

LRMR Latest Press Releases

-- December 18, 2025 --

Larimar Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- November 5, 2025 --

Larimar Therapeutics Reports Third Quarter 2025 Financial Results Globe Newswire 7:00 AM

-- October 30, 2025 --

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - LRMR Business Wire 6:00 PM

-- October 29, 2025 --

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Globe Newswire 12:10 PM

-- October 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:00 AM

-- October 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:09 AM

-- October 22, 2025 --

Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - LRMR Business Wire 12:16 PM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 10:01 AM

-- October 16, 2025 --

Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR PRNewswire 4:44 AM

-- October 15, 2025 --

Larimar Therapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LRMR Business Wire 9:30 PM
LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm Business Wire 9:09 PM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 1:50 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR PRNewswire 4:37 PM

-- September 29, 2025 --

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich's Ataxia Globe Newswire 7:00 AM

-- September 28, 2025 --

Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich's Ataxia Globe Newswire 5:00 PM

-- September 1, 2025 --

3 Best Stocks to Buy Now, 9/1/2025, According to Top Analysts TipRanks 8:09 AM
Market Data Delayed 15 Minutes